INmune Bio surges after announcing XPro1595 decreases biomarkers of neuroinflammation in Alzheimer's patients Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- INmune Bio (INMB) up 37% after announcing that results from a Phase 1b study demonstrate that XPro1595, an investigational dominant-negative protein that neutralizes soluble TNF, decreases biomarkers of neuroinflammation across multiple measures and assays in patients with Alzheimer's disease
- Heartland Express (HTLD) up 2% after earnings and Stifel analyst David Ross upgraded shares to Buy
UP AFTER EARNINGS -
- Truist Financial (TFC) up 1%
- Travelers (TRV) up 2%
- KeyCorp (KEY) up 2%
- Northern Trust (NTRS) up 2%
DOWN AFTER EARNINGS -
LOWER -
- CytomX Therapeutics (CTMX) down 8% after a 14.286M share secondary priced at $7.00
- Inovio (INO) down 6% after a 2.7M share spot secondary priced at $8.50
Symbols:
INMB HTLD TFC TRV KEY NTRS FCEL CTMX INO Keywords: Fly Intel, Wall Street, Top Stories, Stocks